✦ LIBER ✦

Economic assessment of recombinant factor IX in prophylaxis for hemophilia B in young patients in Mexico

✍ Scribed by Muciño-Ortega, E.; Salinas-Escudero, G.; Galindo-Suárez, R.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic assessment of the prophylaxis v

✍ Muciño-Ortega, E.; Salinas-Escudero, G.; Galindo-Suárez, R.M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Pharmacokinetic Study of Recombinant Hum

✍ Hsiu-Hao Chang; Yung-Li Yang; Mei-Hua Hung; Woei Tsay; Ming-Ching Shen 📂 Article 📅 2007 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 237 KB

Potential role of recombinant factor FVI

✍ U. HEDNER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Randomized, prospective clinical trial o

✍ B. A. KONKLE; L. S. EBBESEN; E. ERHARDTSEN; R. P. BIANCO; T. LISSITCHKOV; L. RUS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Cost-effectiveness analysis of prophylax

✍ Ordoñez Molina, J.E.; Orozco Giraldo, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Enhanced pharmacokinetic properties of a

✍ Negrier, C.; Knobe, K.; Tiede, A.; Giangrande, P.; Moss, J. 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 296 KB